Jacqualyn A. Fouse
2014 - Celgene
In 2014, Jacqualyn A. Fouse earned a total compensation of $8.7M as President Hematology and Oncology at Celgene, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $4,867,123 |
|---|---|
| Option Awards | $2,077,620 |
| Salary | $803,250 |
| Stock Awards | $901,257 |
| Other | $22,238 |
| Total | $8,671,488 |
Fouse received $4.9M in non-equity incentive plan, accounting for 56% of the total pay in 2014.
Fouse also received $2.1M in option awards, $803.3K in salary, $901.3K in stock awards and $22.2K in other compensation.
Rankings
In 2014, Jacqualyn A. Fouse's compensation ranked 672nd out of 13,032 executives tracked by ExecPay. In other words, Fouse earned more than 94.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 672 out of 13,032 | 95th |
Division Manufacturing | 242 out of 4,965 | 95th |
Major group Chemicals And Allied Products | 76 out of 1,690 | 96th |
Industry group Drugs | 58 out of 1,369 | 96th |
Industry Pharmaceutical Preparations | 55 out of 1,042 | 95th |
Source: SEC filing on April 28, 2016.
Fouse's colleagues
We found six more compensation records of executives who worked with Jacqualyn A. Fouse at Celgene in 2014.
2014
Robert Hugin
Celgene
Chief Executive Officer
2014
Peter Kellogg
Celgene
Chief Financial Officer
2014
Mark Alles
Celgene
Chief Operating Officer
2014
Thomas Daniel
Celgene
Chairman
2014
Perry Karsen
Celgene
Chief Executive Officer
2014
Scott Smith
Celgene